Sylvie Colin

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 227 citations

Aganirsen Antisense Oligonucleotide Eye Drops Inhibit Keratitis-Induced Corneal Neovascularization and Reduce Need for Transplantation

Claus Cursiefen, Eric Viaud, Felix Bock et al. · Ophthalmology · 2014 · 109 citations · Full text

Antiangiogenic Activity of Aganirsen in Nonhuman Primate and Rodent Models of Retinal Neovascular Disease after Topical Administration

Frank Cloutier, Matthew S. Lawrence, Robin J Goody et al. · Investigative Ophthalmology & Visual Science · 2012 · 51 citations

In Vivo Involvement of Heparan Sulfate Proteoglycan in the Bioavailability, Internalization, and Catabolism of Exogenous Basic Fibroblast Growth Factor

Sylvie Colin, Jean‐Claude Jeanny, Frédéric Mascarelli et al. · Molecular Pharmacology · 1999 · 50 citations

Potent in Vivo Antiangiogenic Effects of GS-101 (5′-TATCCGGAGGGCTCGCCATGCTGCT-3′), an Antisense Oligonucleotide Preventing the Expression of Insulin Receptor Substrate-1

Salman Al-Mahmood, Sylvie Colin, Nada Farhat et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 34 citations